Categories
Change Password!
Reset Password!
Curcumin steps up for women’s metabolic wellness, may help balance blood sugar and cholesterol in PCOS.
A recent scientific analysis published in ‘Health Science Reports’ suggested that curcumin, a centuries-old spice, could significantly improve key cardiometabolic risk factors in women battling polycystic ovary syndrome (PCOS). Rightly so, this bright yellow compound that gives turmeric its colour—may now have a new claim to fame.
PCOS is a complex endocrine disorder that affects millions of women worldwide and is closely linked to increased metabolic and cardiovascular risk, mainly due to heightened oxidative stress. Curcumin’s well-documented antioxidant properties may offer a natural therapeutic pathway to counteract these harmful effects.
Researchers analyzed data from eight randomized controlled trials (RCTs). They found compelling evidence that curcumin supplementation led to substantial reductions in fasting blood sugar, insulin levels, insulin resistance (as measured by homeostasis model assessment of insulin resistance [HOMA-IR]), and total cholesterol. Notably, it also improved insulin sensitivity, as shown by an increase in the quantitative insulin sensitivity check index (QUICKI) index. These findings suggest curcumin’s powerful potential to mitigate the metabolic challenges commonly associated with PCOS.
While the supplement showed little to no effect on certain hormonal and lipid parameters, including body weight, triglycerides, and sex hormones like testosterone and follicle-stimulating hormone (FSH), its marked impact on glucose regulation and cholesterol levels could position curcumin as a valuable adjunct in managing the metabolic complications of PCOS.
Health Science Reports
Impacts of Curcumin Supplementation on Cardiometabolic Risk Factors in Patients With Polycystic Ovary Syndrome: A Systematic Review and Dose−Response Meta-Analysis
Shooka Mohammadi et al.
Comments (0)